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Somatic hypermutation (SHM) of the immunoglobulin variable (IgV) loci is a key
process in antibody affinity maturation. The enzyme activation-induced deaminase (AID),
initiates SHM by creating C→U mismatches on single-stranded DNA (ssDNA). AID has
preferential hotspot motif targets in the context of WRC/GYW (W = A/T, R = A/G, Y =
C/T) and particularly at WGCW overlapping hotspots where hotspots appear opposite
each other on both strands. Subsequent recruitment of the low-fidelity DNA repair
enzyme, Polymerase eta (Polη), during mismatch repair, creates additional mutations at
WA/TW sites. Although there are more than 50 functional immunoglobulin heavy chain
variable (IGHV) segments in humans, the fundamental differences between these genes
and their ability to respond to all possible foreign antigens is still poorly understood. To
better understand this, we generated profiles of WGCW hotspots in each of the human
IGHV genes and found the expected high frequency in complementarity determining
regions (CDRs) that encode the antigen binding sites but also an unexpectedly high
frequency of WGCW in certain framework (FW) sub-regions. Principal Components
Analysis (PCA) of these overlapping AID hotspot profiles revealed that one major
difference between IGHV families is the presence or absence of WGCW in a sub-region
of FW3 sometimes referred to as “CDR4.” Further differences between members of
each family (e.g., IGHV1) are primarily determined by their WGCW densities in CDR1.
We previously suggested that the co-localization of AID overlapping and Polη hotspots
was associated with high mutability of certain IGHV sub-regions, such as the CDRs.
To evaluate the importance of this feature, we extended the WGCW profiles, combining
them with local densities of Polη (WA) hotspots, thus describing the co-localization of
both types of hotspots across all IGHV genes. We also verified that co-localization is
associated with higher mutability. PCA of the co-localization profiles showed CDR1 and
CDR2 as being the main contributors to variance among IGHV genes, consistent with
the importance of these sub-regions in antigen binding. Our results suggest that AID
overlapping (WGCW) hotspots alone or in conjunction with Polη (WA/TW) hotspots are
key features of evolutionary variation between IGHV genes.
Keywords: somatic hypermutation (SHM), activation induced deaminase (AID), immunoglobulin heavy chain,
computational immunology, B cell receptor (BCR), dimensionality reduction, unsupervised learning
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INTRODUCTION

(ncMMR) (9, 28). We further noted, at least for the IGHV323∗ 01 gene, that the most highly mutated sub-regions, such as
the CDRs, appeared to have both WGCW (e.g., AGCT) hotspots
and a high density of Polη hotspots, and that mutations in
the overlapping AID hotspots were associated with increased
mutation levels throughout the whole V region (9, 24, 26, 28),
which raised the possibility that certain WGCW sites might
behave as “activation” sites for attracting AID and enabling
subsequent mutations to these sub-regions. Based on these
possibilities, we hypothesized that the difference in distribution
and abundance of AID overlapping and Polη hotspots in the
germline sequence of the different human IGHV genes, and their
relationship to the frequency and distribution of mutations, will
provide new insights into how we generate antibody diversity.
Note that we will refer to the preferred motifs for both AID
and Polη as “hotspots” throughout, since this is how they are
conventionally referred to, although this does not necessarily
mean each such “hotspot” is highly mutated.
In this study, we began by analyzing the human IGHV genes
based solely on their distribution of AID overlapping (WGCW)
hotspots using a moving window approach. Interestingly,
WGCW sites are found at high frequency not only in the CDRs,
as one would expect, but also in two FW sub-regions. Using
dimensionality reduction—in this case Principal Components
Analysis (PCA) which uses statistical learning to transform
a large set of possibly correlated variables into a new set of
meaningful and uncorrelated variables—we found that the interfamily differences in IGHV genes are characterized by the
differential distribution of AID overlapping hotspots in two
FW sub-regions: one at the 5′ end of FW1; and the other in
a sub-region of FW3 known informally as “CDR4” (29). At
the same time, intra-family differences can be also described
in terms of variation of WGCW hotspots in CDR1. This
apparent difference in intra-family and inter-family variation
is particularly interesting since it is unclear why most of the
human variable region families have only 1–12 members while
the IGHV3 family has 25 productive germline genes and several
non-productive genes. Based on these findings, we sought to
develop a strategy for characterizing and comparing all of the
human IGHV genes based on a simple profile that uses the colocalization of both AID overlapping and Polη WA/TW hotspots
to account for possible interactions between AID and MMR. PCA
of these profiles revealed that variation within the IGHV genes
can also be characterized in terms of the germline distribution
of co-localized AID overlapping and Polη hotspots observed
mostly within CDR1 and CDR2, and to an extent FW3. With the
inclusion of non-functional IGHV genes (e.g., pseudogenes), we
observed markedly reduced co-localized hotspots in CDR1 and
CDR2 while the numbers in FW3 remain the same compared to
functional IGHV genes.

The affinity maturation of antibodies is a key part of the immune
response against infectious diseases and vaccines. In the dark
zone of the Germinal Center (GC), B cells undergo somatic
hypermutation (SHM) of the immunoglobulin (Ig) variable (V)
regions, accumulating mostly point mutations. As they move to
the GC light zone, these B cells are also subject to selection with
a preference for those B cells that gained favorable mutations
leading to higher affinity binding B cell receptors (BCRs) (1–
3). Expression of the mutagenic enzyme activation-induced
deaminase (AID) in activated B cells is necessary to initiate SHM
(4) by deaminating cytosine (C) to uracil (U) in single-stranded
DNA (ssDNA) (5). Subsequent downstream error-prone DNA
repair pathways—non-canonical base-excision repair (ncBER)
and mismatch repair (ncMMR)—may be activated following the
initial deamination event (6). As a consequence, mutations arise
at the site of the original U:G mismatch due either to bypass
during replication or BER involving Uracil DNA glycosylase
(UNG), and at surrounding adenine (A) and thymine (T) bases
due to MMR mediated by the low-fidelity polymerase Polη (7–9).
Previous studies of SHM data have shown that mutations
are strongly biased toward particular IgV sites and sub-regions
in several ways. Most clearly, mutations are biased toward the
CDRs that correspond to the antigen binding sub-regions of the
antibody protein, rather than the structural FW regions (10–12).
Consistent with this, previous phylogenetic analyses of Ig heavy
chain V (IGHV) genes in both human and mouse suggested
there was stronger diversifying selection at the evolutionary level
within CDRs compared to FWs (13, 14). Early work had also
found that codons within the CDRs are more likely to lead to
amino acid changes than codons for the same amino acid in
the FW regions (15, 16). More recent studies have extended
these results for all codons using approaches that take into
account relative mutability (17, 18). As more antibody sequence
data have become available, several studies have considered
the importance of selection during SHM and have shown
that intrinsic mutational bias is surprisingly strong relative to
selection effects. For example, a comparison of non-productive
sequences, which reflect the underlying mutation process in
the absence of selection, with productive sequences from the
human IGHV3-23 gene, found that the mutation profiles were
highly similar (19), highlighting the importance of the intrinsic
mutational bias.
At the micro-sequence level, it has been known for a
long time that there exist sequence motifs, or “hotspots,”
that are preferentially targeted during SHM (20). When AID
was discovered and characterized biochemically, its preferential
targeting to ssDNA with the motif WRC/GYW (W = A/T,
R = A/G, Y = C/T) was confirmed, where the underlined
base indicates the mutated site on the upper and lower strand
respectively (21–23). Subsequent studies by ourselves (24) and
others (25–27) confirmed the importance of overlapping AID
hotspots (defined by the motif WGCW) in attracting mutations,
particularly during the earliest rounds of SHM. In addition,
mutations found in A:T bases stemming from WA/TW motifs
are hallmark footprints left by Polη during non-canonical MMR
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Data from the memory, marginal zone, and plasma cell subsets
(B10-B14, B16-21, HD001-10) from 21 healthy individuals
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IMGT and linear interpolation, a curve-fitting method, to
adjust for differences in IGHV sequence lengths using the R
function approx. Lastly, allelic variants were ignored and only
∗ 01 alleles were used except where indicated otherwise. For
Principal Components Analysis (PCA), the hotspot distribution
profiles were used as input, which was performed using the R
function prcomp.

from NCBI SRA BioProjects 381394 and 591804 were used in
this study.

Data Preprocessing
Datasets were processed using pRESTO, Change-O, and
TIgGER toolkits, part of the Immcantation framework
(https://immcantation.readthedocs.io/en/version-2.6.0/).
As previously described in Vergani et al. (30), barcoded
(labeled with Unique Molecular Identifier, UMI) Illumina
MiSeq sequences were assembled using pRESTO, with
low quality reads (Q < 20) and reads observed only once
(CONSCOUNT<2) being removed. Resulting FASTA files
were then submitted to IMGT/High-VQuest to identify
IGHV gene assignments and CDR3 boundaries. In order to
avoid possible effects of selection, only sequences identified
as non-productive due to frameshifts or stop codons in
CDR3 by IMGT were used, since such rearranged V regions
were non-productive from the time of VDJ rearrangement
(31). The Change-O package was then used to determine
clonal groups based on the CDR3 sub-region, separately for
each individual dataset (each corresponding to a separate
human individual). To avoid issues arising from clonality, we
randomly selected one sequence per clone for the analysis.
Only V segments, excluding the CDR3 and J, were used in
the following analysis. We also used the TIgGER package to
identify possible novel (non-IMGT) alleles. Any sequences
assigned to novel alleles were removed in order to avoid
the associated polymorphisms generating false-positive
“mutations” (32). All subsequent analysis was performed
using custom R scripts.

Correction for Hotspot Composition in the
WGCW/WA Profiles
As expected due to their lower motif complexity, WA
hotspots are more abundant, making the scale of their profile
generally higher in absolute terms. Thus, before calculating
the product of the two profiles, we rescaled the WA/TW
profiles by 1/12, which corresponds to the difference in
expected frequency given a random and equiprobable nucleotide
background (frequency of WA or TW: 3/(42 ) = 3/16;
frequency of WGCW: 4/(44 ) = 1/64). As before, we used
linear interpolation to ensure all profiles have the same
sequence length.

Classifying WGCW/WA Sub-regions
We used thresholding to discretize (convert to TRUE/FALSE
values) the profiles describing co-localization of AID WGCW
overlapping and Polη WA/TW hotspots (see Figure S3). In other
words, we defined a cutoff value that classified each site of
every distribution profile as either falling within (TRUE), or
outside (FALSE) the WGCW/WA co-localization sub-region.
When deciding on a threshold value we observed that if the
threshold was set too low then, for certain V genes, both
CDRs would be entirely above the threshold, leaving no belowthreshold sub-region to compare with, in which case the V
gene would have to be removed from the analysis. On the
other hand, if the threshold was set too high, then for some
V genes there would be no sites recognized as belonging
to the WGCW/WA sub-region, particularly in FW regions,
again leading to removal of these genes. We identified an
optimal range of threshold values for which there was the
least number of V genes removed due to either of these
effects, and then defined the midpoint of this range as the
threshold value for further analysis. With the sites for each
V gene thus discretized, we counted mutations falling into
the WGCW/WA co-localization sub-region and those outside
separately. If there were not enough sequences from the ∗ 01 allele,
then alternative alleles were used if these had enough data—
in practice the only alternative alleles used were IGHV1-2∗ 02,
IGHV3-49∗ 03, IGHV4-4∗ 02, and IGHV5-10-1∗ 03 for CDRs;
and IGHV1-45∗ 02, IGHV3-49∗ 03, and IGHV4-4∗ 02 for FW
regions. To test for significance of mutations within WGCW/WA
sub-regions, we implemented a one-sided binomial test using
the R function binom.test using the proportion of sites within
the WGCW/WA co-localization sub-region as the parameter
for expected p. The resulting FDR-corrected binomial test Pvalues (Benjamini-Hochberg method) were calculated using the
R function p.adjust.

Germline Sequence Data
The human germline IGHV genes used in the analysis
were downloaded from the international ImMunoGeneTics
information system (IMGT) website (www.imgt.org). We
distinguished CDR and FW boundaries according to the unique
IMGT numbering scheme. Gapped germline sequences were
truncated to 294 nt to avoid possible nucleotide addition at the
junction of FW3 and CDR3 in our dataset.

Generating Hotspot Profiles for All IGHV
Genes
The starting point for our analysis is the distributions of AID
WGCW and Polη WA/TW hotspots (Figures S1, S2 for the
IGHV3 family, and other the 6 IGHV families, respectively).
To generate the hotspot profiles for each IGHV germline
gene, as described in the main text, we used a moving
window of size 15 nt both upstream and downstream of
each nucleotide position (for a total window size of 31),
counting the number of hotspots of interest, and then dividing
by the total window size. In other words, each sequence
is represented as a hotspot distribution profile where each
value measures the hotspot density in the neighborhood
around each position in the sequence. To ensure that the
distribution profiles were of equal length for subsequent analyses
(see below), we used the standard gapped alignments from
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an example, Figure 1A shows the WGCW profile for IGHV169∗ 01, one of the most commonly used human IGHV genes,
and which also contains a high number of WGCW sites. The
window size of +/– 15 nt was chosen to be comparable to
the size of a typical CDR 1 or 2 sub-region (maximum widths
using IMGT scheme, CDR1: 36 nt, CDR2: 30 nt), although
varying this parameter does not qualitatively change the results
as will be described below (Figure S4). Figure 1B shows the
mean and one standard deviation of these profiles for the set
of 56 functional human IGHV genes in IMGT. The highest
average level of overlapping AID hotspots was located in a
small sub-region of highly conserved WGCW sites at the 5′
end of FW1. This is a highly conserved cluster of overlapping
AID hotspots in all families except IGHV2 (Figures S1, S2)

Overlapping Hotspot Densities Vary
Greatly Between Multiple Sub-regions of
the V Region
Given the importance of overlapping hotspots as prime sites of
AID targeting (21–23, 25), as well as their influence on enhanced
mutability throughout the V region in IGHV3-23∗ 01 as we
had observed previously (24), we now examined all functional
human IGHV genes to identify similarities or differences in
terms of overlapping AID hotspot distributions. We constructed
profiles for each IGHV gene using a sliding window of +/– 15
nt around each position to describe the surrounding frequency
of overlapping AID hotspots (see Materials and Methods). As

FIGURE 1 | Identifying WGCW hotspot regions. (A) We show the moving window profile for WGCW overlapping AID hotspots for IGHV1-69. The shaded areas mark
CDR1 and CDR2. (B) Site-by-site calculation of the average number of WGCW hotspots found in a window of size 31 (+/– 15 nt around each site). The bold line
indicates the average across the 56 human IGHV genes and is colored according to sub-region. The shaded region represents +/– 1 standard deviation at each site.
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CDR1 loadings largely track with PC2 and that FW1 and FW3
loadings track with PC1 (as do, to a lesser extent, those of CDR2),
it suggests that CDR1 variation is independent (uncorrelated)
with both variation in FW1 and FW3, and CDR2.
To explore these independences of variation further, we
selected sets of sites along PC1 or PC2 with loadings that are
furthest from the origin and contribute most to the variation as
indicated by the areas enclosed by the lines in Figure 2B, which
are colored according to the most abundant sub-region (CDR1,
CDR2, or FW3) within each set. Note that some FW2 sites (blue)
that are adjacent to the 3′ end of CDR1 were included as part of
the CDR1 set (Figure 2B; Figures S1, S2). We then calculated, for
each gene separately, the mean overlapping hotspot frequency for
each set of sites (here FW1 and FW3 sites were at first considered
separately), giving four mean values for each of the 56 genes.
Pairwise correlations between the four sets (CDR1, CDR2, FW1,
FW3) were then calculated (Figure S5). As expected, FW1 and
FW3 were positively correlated (Figure S5A; Pearson’s ρ = 0.76,
P = 1.34 × 10−11 ), so we combined these sites into one set
(FW1/3) thereafter. On the other hand, we found that the FW1/3
set was negatively correlated with the CDR2 set (Figure S5B;
Pearson’s ρ = −0.52, P = 3.92 × 10−5 ). There was also no
significant correlation between the CDR1 set and the CDR2
set (Figure S5C; Pearson’s ρ = 0.08, P = 0.568), as well as
between the CDR1 set and the FW1/3 set (Figure S5D; Pearson’s
ρ = 0.08, P = 0.535). Because PC1 explains more variation
than PC2, and because sites in FW1/3 make the largest PC1
contributions, our results suggest that the presence or absence of
overlapping hotspots in FW1 and FW3 explain major differences
in IGHV genes. CDR1 is also a major contributor to variation,
with patterns of overlapping hotspots that are independent of
those of FW1/3.

whose presence is rarely recognized and function is not known.
The next two largest peaks, which are shared by all of the
IGHV genes and are roughly of equal magnitude, are found
in CDR1 and, somewhat surprisingly, in FW3, as opposed to
CDR2, which has a mean density roughly half that of CDR1
(Figure 1B). Interestingly, CDR1 contains an additional lower
peak, driven by a single AID overlapping hotspot just 5′ to
CDR1 in almost all of the IGHV3, IGHV1, and IGHV2 family
members (Figure 1B; Figures S1, S2). The relatively high density
of overlapping hotspots in FW1 and FW3 is, in a way, unexpected
given that FW regions generally have lower mutation frequencies
than the CDRs. We further noted that the peaks were more-orless evenly spaced at intervals of ∼85 nt. Also, the variance was
high in all four sub-regions, suggesting that over evolutionary
time, substantial differences have arisen between the IGHV genes
in terms of the frequency of AID overlapping hotspots within
each sub-region.

FW1 and FW3 Display a Greater
Contribution to Overlapping Hotspot
Variation Than the Other Sub-regions
In order to identify common patterns of overlapping AID
hotspots among the IGHV genes and to better describe
associations between the sub-regions, we performed Principal
Components Analysis (PCA) using the overlapping hotspot
distribution profiles for each gene (see Materials and Methods).
The newly transformed variables resulting from PCA, called
principal components (PCs), are calculated such that the most
variation (maximum variance) of the WGCW distribution
profiles is captured by the first PC, the second PC explaining
the next most variation from the remaining variance, and so on.
Another useful feature of PCA is that all PCs are uncorrelated
with one another. The transformed data are commonly shown
projected onto a plot using PC1 (x-axis) and PC2 (y-axis),
crossing at the origin (i.e., where the axes intersect), where data
points that have similar features are expected to cluster together.
Figure 2A, known as the PCA scores, shows such a plot. Here,
each of the IGHV genes, colored by gene family, are projected
onto the first two PCs, which reflect the two major independent
variances in the distributions of the WGCW overlapping AID
hotspots. These projections illustrate how individual IGHV genes
are distributed spatially with respect to PC1 and PC2.
Figure 2B shows the corresponding PCA loadings, which
describe the contribution of each site on the sequence
(represented by color-coded dots) to the overall variation. The
magnitude of the PCA loadings, either positive or negative,
quantifies the strength of their contribution to the variance, so
loading values far from the origin represent larger contributions
whereas those close to the origin are smaller. In the loadings
plot in Figure 2B, each dot represents a site and is color-coded
according to the sub-region (CDR1-2, FW1-3). If we consider
sites that are far from the origin, we observe a clear separation
between the CDR1 sites (orange) on the one hand, and FW1
(black) and FW3 (green) together on the other. CDR2 sites (red)
also appeared along PC1 in the opposite direction to the FW1
and FW3 sites, albeit to a lesser degree. Because we observed that
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IGHV Families Group by Their Densities of
Overlapping Hotspots in FW1 and FW3
The PCA loadings (Figure 2B) are useful in explaining how the
IGHV genes have clustered in the PCA scores plot (Figure 2A).
Along PC1 (the PC that explains the greatest amount of variance),
IGHV genes largely group by family, as one might expect, with
the exception of the IGHV1 family, for which the range includes
the IGHV4 family cluster. As suggested by the pattern of loadings
along PC1, these inter-family differences emerge due to the
presence or absence of overlapping hotspots within FW1 and
FW3 since IGHV genes that yield high negative contributions to
PC1 will be those containing overlapping hotspots in FW1 and
FW3 that are associated with negative loadings (Figure 2B). It is
important to note that the sign of the loadings are, in a sense,
arbitrary since changing their signs—from positive to negative,
and vice versa—would not qualitatively change the results (i.e.,
the positional arrangement of IGHV genes would remain the
same on the plot); rather it is the magnitude of the loading
contribution that is more telling because it determines where
in the scores plot (Figure 2A) the IGHV genes are positioned.
To demonstrate this effect, IGHV1-69, for instance, contains
three WGCW hotspots in CDR1 as well as another one just 3′
of CDR1; it also contains several overlapping hotspots in both
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FIGURE 2 | Principal components analysis (PCA) of functional human IGHV genes. (A) PCA transformation of the WGCW hotspot distribution profiles for 56 functional
human IGHV genes analyzed, known as PCA scores, with respect to the first two principal components (PC1 and PC2). The amount of variance from the WGCW
hotspot distribution profiles captured by each PC is shown in parentheses. Each gene is colored according to its corresponding IGHV family. Gene labels located far
from their corresponding dot are attached by a fine line to overcome the problems of overlapping and nearby numbers. (B) PCA loadings plot where each dot
represents a site and its relative contribution to each of the first two PCs. Distance from the origin (where PC1 and PC2 intersect) signifies the magnitude of each site’s
loadings contribution. Colors indicate the sub-region of each site. Dots enclosed by colored lines indicate high-contributing sites for each category (CDR1, CDR2,
FW3).

(Figure 2A), have four overlapping hotspots located at the 5′
end of FW1 and three or more additional overlapping hotspots
around positions 250–280 of FW3 (Figure S2). At the other
extreme of PC1 (right side of Figure 2A), the IGHV2 family is
exceptional in that it does not have any overlapping hotspots
within the first 25 nt at the 5′ end of FW1 or in the hypervariable
area of FW3 (Figure S2), which is again consistent with the
corresponding loadings (green delimited area in Figure 2B).
Furthermore, it is also important to know that loadings that
are along the same PC but located in opposite directions from

FW1 and FW3 (Figure S2). Because those sites found further
along negative PC1 (to the left of the origin) are associated with
FW1 and FW3, and because CDR1 sites are generally found
along positive PC2 (upward from the origin) (Figure 2B), any
gene containing hotspots in both sub-regions, such as IGHV169, will be forced toward the upper-left quadrant of the scores
plot (Figure 2A).
In addition, the relationships between the PCA scores and
loadings can also be extended to entire gene families. Most
obviously, the IGHV5 family genes, at the left side of PC1
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Clusters of Co-localized Polη Hotspots and
AID Overlapping Hotspots Are Associated
With Higher Mutation Frequencies

the origin, signify that they contribute to variation in opposing
ways. Since we found sites in FW1/3 to be negatively correlated
with sites in CDR2 (Figure S5B), we also expected to find
differences between the IGHV2 and IGHV5 families with respect
to overlapping hotspot(s) in CDR2. For example, there is a TGCA
hotspot at the 3′ end of FW2, next to CDR2, that occurs only in
the IGHV2 family (Figure S2).
The IGHV5 and IGHV2 gene families represent two extremes
of a spectrum that explains a large amount of variation in
overlapping hotspot densities between IGHV families, ranging
from the greatest to the least number of overlapping hotspots
contained in FW1 and FW3. The remaining IGHV families fall
between these two extremes. For example, some members of the
IGHV1 family, such as IGHV1-58, 1-69, and 1-69D, as well as the
lone IGHV7 gene, IGHV7-4-1, are very similar to IGHV5 genes
in that they contain three overlapping hotspots in FW1 as well as
three more hotspots in FW3 (Figure S2). Of note, this particular
sub-region of FW3 includes one of two previously reported nonCDR regions of hypervariability [nt positions 256–273 (29), and
is also referred to as “CDR4”]. On the other hand, there are some
IGHV3 family genes, such as IGHV3-53, 3-64, and 3-13, that are
missing overlapping hotspots in the hypervariable sub-region of
FW3 (Figure S1), and therefore, are found to be closer to the
IGHV2 family.

Our previous analysis of the IGHV3-23 gene (24) noted that
the CDRs appeared to have a co-localization of overlapping
AID hotspots, in this case AGCT, with clusters of WA/TW
motifs. Mutations occurring in WA/TW hotspots are associated
with the error-prone DNA repair enzyme, Polη, as part of
the non-canonical mismatch repair (ncMMR) pathway which
often acts downstream of AID-deamination at nearby C residues
(3). As above where we considered only WGCW sites, we
wanted to search for possible interactions between AID and
Polη hotspots over a range that was at least as wide as CDR1
or CDR2 (again using +/– 15 nt) in all human IGHV genes
(see below).
We first sought to identify potential sub-regions for
heightened AID and Polη interactions by defining a formal, yet
simple, measure to quantify this synergy across all IGHV genes.
In a similar way to the AID overlapping hotspot distributions
that we calculated previously (as shown in Figure 1A for IGHV
1-69, and repeated in Figure S3A), we calculated equivalent
distribution profiles for Polη WA (TW on opposite strand)
hotspots (Figure S3B) for all of the genes using the same
method described above for characterizing WGCW motifs. We
then defined a measure for the co-localization of both AID
overlapping and Polη hotspots as the site-by-site product of the
WGCW and WA/TW profiles (Figure S3C), correcting for the
relatively greater abundance of WA/TW hotspots (see Materials
and Methods). As a result, we have generated profiles for each
IGHV gene that identify the sub-region(s) in each gene where
there is a co-localization of both WGCW and WA/TW motifs.
Due to the presence of mutational hotspots, we obviously
expected the sub-regions identified as containing both WGCW
and WA/TW motifs to be functionally relevant and therefore
more highly mutated in vivo. To verify this using mutation
data, we began by categorizing each site either as belonging to a
WGCW/WA sub-region or not using the co-localization profiles
for each gene. We used a single threshold value to separate
the two categories. The threshold was chosen so we could
include as many V genes as possible (see Materials and Methods;
Figure S3C). Next, we used a large dataset of high-quality IGHV
repertoire data from non-productive, and therefore not antigenselected sequences, to obtain mutation data for different human
IGHV genes where each V region was represented by at least 100
sequences with multiple mutations (see Materials and Methods).
We utilized the mutation data for the corresponding IGHV gene
to count the mutations occurring both within and outside the
WGCW/WA sub-regions.
The violin plots in Figure 3 show, for each IGHV gene,
the distribution of mutation frequencies for sites within the
WGCW/WA sub-regions (blue distributions) and outside these
sub-regions (red distributions). The mutation frequencies within
the WGCW/WA sub-regions are significantly higher (using a
t-test) for almost all IGHV genes (39/43) that we considered
(Figure 3). As an alternative comparison, the mutation counts
within each WGCW/WA sub-region were compared (using a

Differences Within IGHV Families Are
Primarily Determined by Overlapping
Hotspots in CDR1
Since varying densities of overlapping hotspots in FW1 and FW3
appear to determine differences between the IGHV families,
we suspected that the remaining variation, which we had
already found to be high in CDRs (Figure 1B), would be
associated with intra-family differences. We began by analyzing
the two largest IGHV families, IGHV3 and IGHV1, which
account for approximately two-thirds (37/56) of the functional
genes and appear to have more variable overlapping hotspot
distributions in both CDRs as compared to the other gene
families (Figures S1, S2).
We noted earlier that CDR1 is a region with a high density
of overlapping AID hotspots and very high variance (Figure 1B).
Given the loadings pattern (orange-delimited area in Figure 2B),
we expected differences along PC2 to reflect the number of
WGCW hotspots specifically in CDR1 and the 5′ edge of FW2.
Thus, genes such as IGHV3-30 and 3-23 that are in the positive
PC2 direction (Figure 2A) contain at least one overlapping
hotspot in CDR1, whereas genes such as IGHV3-72, that are
in the negative PC2 direction, have no overlapping hotspots
in CDR1 (Figure S1). The IGHV1 family is similar, with genes
such as IGHV1-69 (top of Figure 2A) having many overlapping
hotspots in CDR1 and others such as IGHV1-8 having none
(bottom of Figure 2A; Figure S2). These examples are only a
couple of the many other instances that highlight this sort
of intra-family difference. IGHV genes belonging to the same
family, combined with high variance primarily in CDR1 (as noted
in Figure 1B), confirmed that CDR1 was the major source of
intra-family variation.

Frontiers in Immunology | www.frontiersin.org

7

April 2020 | Volume 11 | Article 788

Tang et al.

Evolutionary Variation of Antibody Genes

FIGURE 3 | Distribution of mutation frequency between WGCW/WA sub-regions and non-WGCW/WA sub-regions. The distribution of the observed mutation
frequencies is shown separately for WGCW/WA sub-regions (blue), and non-WGCW/WA sub-regions (red) for each individual IGHV gene. One-sided t-tests
comparing the two distributions were performed for each gene. Significant p-values are indicated by asterisks above each plot (*p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001).

WGCW/WA sub-regions were not more highly mutated in
that gene.

binomial test, see Materials and Methods) to their expected
value, defined as the relative proportion of sites found within the
WGCW/WA sub-regions (Table 1). This comparison confirmed
that WGCW/WA sites acquire more mutations than expected for
all IGHV genes considered. Because CDRs would be expected
to mutate more than FW regions and therefore be enriched for
hotspots (CDRs contain on average 50.67% ± 20.67 WGCW/WA
sites compared to 5.88% ± 4.22 for the FW regions), we also
considered CDR and FW regions separately (Table S1 for CDRs;
Table S2 for FWs). Note that for certain IGHV genes in this
dataset, we found no observed mutations either within the
WGCW/WA sub-region or, in other cases, outside the subregion. In such cases, the genes were removed (independently
for CDR and FW), leaving 40 and 41 IGHV genes for CDR
and FW regions, respectively, to be used for this analysis.
When considering only the CDR regions, we still found that
the WGCW/WA sub-regions mutated at a significantly higher
frequency than non-hotspot containing regions in 30 out of 40
(75%) IGHV genes (Table S1). Similarly, when we considered
the FW regions, we found a significantly higher frequency in
29 of the 41 (71%) of IGHV genes (Table S2). Furthermore,
we consider these results to be conservative since for some
genes, the percentage of WGCW/WA sites is very high (e.g.,
45/48 sites = 93.8% for IGHV3-23 in Table S1), leaving only
a small number of sites to compare against, which in turn
reduces statistical power giving the false impression that the

Frontiers in Immunology | www.frontiersin.org

Patterns of Co-localized Overlapping AID
and Polη Hotspots Characterize Variation
in CDRs 1 and 2 Across IGHV Genes
We repeated the PCA analysis but now examined the profiles
of co-localized overlapping AID hotspots and Polη hotspots.
Similarly to what we had observed previously using the AID
WGCW distribution profiles (Figure 2A), IGHV genes tended
to cluster by families after PCA transformation of the individual
co-localization profiles (Figure 4A). In comparison to the PCA
analysis using only WGCW sites (Figure 2B), here the PCA
loadings revealed sites in CDR1 and CDR2 to be the foremost
contributors to variation (Figure 4B). We also observed little
contribution of FW1 sites to overall variation, due to Polη
hotspots mostly being absent from the recurrent sub-region of
AID overlapping hotspots in the 5′ end of FW1 (Figures S1, S2).
FW3 sites similarly appear to have a reduced contribution to
variation, however, the co-localization of WGCW and Polη
sites that does occur appears to be due to the sites at around
positions 250–275 in FW3 that also contain recurrent hotspots
(Figures S1, S2).
Co-localization of AID WGCW and Polη hotspots therefore
appears to focus on CDRs 1 and 2 as key drivers of variation
between IGHV genes. Interestingly, the loadings (Figure 4B) for
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TABLE 1 | Binomial test results showing mutability of all WGCW/WA sites (CDRs + FWs).
Allele

IGHV1-2*02
IGHV1-3*01
IGHV1-8*01
IGHV1-18*01
IGHV1-24*01
IGHV1-45*02

Num mutations Num mutations Total num Percent mutations
within
outside
mutations
within
WGCW/WA sites WGCW/WA sites
WGCW/WA regions
960
2,380
907
7,472
76
75

13,928
7,684
7,931
11,325
3,840
1,738

14,888
10,064
8,838
18,797
3,916
1,813

6.4
23.6

Num
WGCW/WA
sites

IGHV gene
length
(ungapped)

Percent
WGCW/WA
sites

P-value

Corrected
P-value

10

270

3.7

P < 10−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

31

10.3

18

39.8

57

1.9

3

4.1

8

270
270
270
270
270

11.5
6.7
21.1
1.1
3.0

4.52 × 10

−6

4.86 × 10−6

3.04 × 10

−3

3.11 × 10−3

P < 10

−20

P < 10−20

IGHV1-46*01

4,032

7,368

11,400

35.4

51

270

18.9

IGHV1-58*01

459

2,153

2,612

17.6

33

270

12.2

IGHV1-69*01

3,399

5,778

9,177

37.0

54

270

20.0

P < 10−20

P < 10−20

IGHV2-5*01

130

3,706

3,836

3.4

7

273

2.6

1.14 × 10−3

1.19 × 10−3

1.56 × 10−15

1.77 × 10−15

IGHV2-26*01

956

2,896

3,852

24.8

43

273

15.8

P < 10−20

P < 10−20

IGHV3-7*01

4,731

12,711

17,442

27.1

40

270

14.8

P < 10−20

P < 10−20

IGHV3-9*01

5,192

16,114

21,306

24.4

30

270

11.1

P < 10−20

P < 10−20

IGHV3-13*01

4,349

9,487

13,836

31.4

48

267

18.0

P < 10−20

P < 10−20

IGHV3-15*01

2,546

6,362

8,908

28.6

45

276

16.3

P < 10−20

P < 10−20

11.9

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

P < 10

−20

P < 10−20

−20

P < 10−20
P < 10−20

IGHV3-20*01
IGHV3-21*01
IGHV3-23*01
IGHV3-30-3*01
IGHV3-30*01
IGHV3-33*01
IGHV3-43*01

764
3,446
17,854
3,907
751
6,621
908

2,441
13,941
31,432
4,442
2,813
12,254
1,869

3,205
17,387
49,286
8,349
3,564
18,875
2,777

23.8

32

19.8

28

36.2

54

46.8

68

21.1

40

35.1

45

32.7

52

270
270
270
270
270
270
270

10.4
20.0
25.2
14.8
16.7
19.3

IGHV3-48*01

1,052

4,097

5,149

20.4

28

270

10.4

P < 10

IGHV3-49*03

1,432

1,737

3,169

45.2

82

276

29.7

P < 10−20

IGHV3-53*01

2,170

5,770

7,940

27.3

35

267

13.1

P < 10−20

P < 10−20

IGHV3-64*01

1,321

1,022

2,343

56.4

84

270

31.1

P < 10−20

P < 10−20

IGHV3-66*01

951

2,740

3,691

25.8

35

267

13.1

P < 10−20

P < 10−20

IGHV3-72*01

1,142

2,444

3,586

31.8

44

276

15.9

P < 10−20

P < 10−20

IGHV3-73*01

1,192

1,412

2,604

45.8

72

276

26.1

P < 10−20

P < 10−20

18.1

−20

P < 10−20

IGHV3-74*01
IGHV4-4*02
IGHV4-30-2*01
IGHV4-30-4*01
IGHV4-31*01
IGHV4-34*01
IGHV4-38-2*01
IGHV4-39*01

3,855
529
382
451
455
1,746
294
3,202

6,355
6,769
3,862
3,236
1,632
25,944
1,739
8,585

10,210
7,298
4,244
3,687
2,087
27,690
2,033
11,787

37.8

49

7.2

14

9.0

16

12.2

22

21.8

35

6.3

16

14.5

24

27.2

38

270
270
273
273
273
267
270
273

5.2
5.9
8.1
12.8
6.0
8.9
13.9

P < 10

3.09 × 10

−14

3.41 × 10−14

3.01 × 10

−16

3.50 × 10−16

1.89 × 10

−18

2.32 × 10−18

P < 10

−20

1.51 × 10−2

−16

2.35 × 10−16

1.51 × 10
1.96 × 10

P < 10−20

−2

P < 10

−20
−20

P < 10−20
P < 10−20

IGHV4-59*01

2,085

15,502

17,587

11.9

20

267

7.5

P < 10

IGHV4-61*01

438

2,059

2,497

17.5

27

273

9.9

P < 10−20

P < 10−20
P < 10−20

694

2,589

3,283

21.1

39

270

14.4

P < 10−20

IGHV5-51*01

2,584

12,755

15,339

16.8

34

270

12.6

P < 10−20

P < 10−20

IGHV6-1*01

3,610

8,402

12,012

30.1

51

279

18.3

P < 10−20

P < 10−20

IGHV7-4-1*01

1,394

3,237

4,631

30.1

43

270

15.9

P < 10−20

P < 10−20

IGHV5-10-1*03

Expected mutation probability (“Percent WGCW/WA Sites”) is (number of WCGW/WA sites)/(IGHV gene length ungapped). Observed fraction of mutations in (“Percent Mutations in
WGCW/WA sites”) WGCW/WA sites is (number of mutations in WGCW/WA sites)/(total mutations). P-value is for binomial test, both raw and FDR-corrected (see Materials and Methods).

obtaining two values for each IGHV gene that represent the
level of WGCW and WA co-localization for CDR1 and CDR2.
We then calculated the correlation between the CDR1 and
CDR2 values across all IGHV genes, and found it was not
significant (Pearson’s ρ = −0.09, P = 0.51; data not shown),

CDR1 and CDR2 appear to be orthogonal (extending out at
approximately right angles to each other), which further suggests
that the patterns between CDR1 and CDR2 are independent.
To analyze this further, we used the co-localization profiles
to calculate the mean values within CDR1 and CDR2, thus
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FIGURE 4 | PCA analysis of overlapping AID (WGCW) and Polη (WA/TW) hotspots. Plots equivalent to Figure 2 but using the combined overlapping AID and Polη
(WGCW/WA) hotspot distributions. (A) Corresponding PCA scores of the co-localized profiles. Gray arrows point to IGHV genes with co-localized profiles enriched in
CDR1; and black arrows indicate IGHV genes with an especially strong co-localization signal focused in CDR2. (B) Corresponding PCA loadings colored according to
relevant sub-region. Gene labels located far from their corresponding dot are attached by a fine line to compensate for overlapping nearby labels.

Non-functional IGHV Genes Have Reduced
Overlapping Hotspots in the CDRs

consistent with the PCA loadings. Also consistent with these
observations, although many IGHV genes have co-localized
AID overlapping and Polη hotspots in both CDR1 and CDR2,
several have the pattern solely in CDR1 or CDR2. The PCA
scores highlight some of these cases (Figure 4A). Within the
IGHV3 family, for example, IGHV3-21, IGHV3-48, and IGHV330 (gray arrows on the left side of the plot of Figure 4A) have
the co-localization pattern in CDR1 only, and not in CDR2
(Figure S6A). In contrast, other IGHV3 family genes such as
IGHV3-64 and 3-73 (black arrows on the extreme right side
of Figure 4A) have co-localization profiles in both CDRs, but a
strong signal predominantly in CDR2. IGHV3-73, in particular,
has four overlapping hotspots, an exceptionally high number, in
or adjoining CDR2 and in the 5′ region of FW2 together with
many WA sites (Figure S6B).

Frontiers in Immunology | www.frontiersin.org

Thus far we only considered genes defined by IMGT as
functional. However, the human IGHV locus contains many
non-functional genes, which can be categorized as either
pseudogenes or open reading frames (ORFs). Pseudogenes
contain coding region stop codon(s) and/or frameshift
mutations, whereas ORFs contain alterations in splicing
sites, recombination signals and/or regulatory elements leading
to non-functionality (33). To gain further insight into the
possible evolutionary causes of loss of functionality in IGHV
genes, we generated co-localization profiles for the 32 nonfunctional genes. The co-localization profiles of functional genes
(Figure 5A) and non-functional genes (Figure 5B) revealed a
striking difference in the magnitude of the WGCW/WA signal
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FIGURE 5 | Co-localized WGCW/WA profiles for functional and non-functional IGHV genes. Site-by-site calculation of the average number of WGCW/WA co-localized
hotspots of found in a window of size 31 (+/– 15 nt around each site) for (A) functional IGHV genes and (B) non-functional IGHV genes. The bold line indicates the
average across the respective genes and is colored according to sub-region. The shaded region represents +/– 1 standard deviation at each site.

located in the CDRs, with functional genes having a signal about
double the magnitude as non-functional genes in both CDR1
and 2. On the other hand, there appears to be no change in
the co-localization signal in FW3 (Figure 5). As a consequence
of the reduction, for non-functional genes, in the number of
sub-regions containing AID overlapping and Polη hotspots in
the CDRs (Figure S7), we can speculate that this then leads to
an increased relative importance of FW3 (Figure 5B). Although
non-functional genes will accumulate mutations as they evolve,
due to the absence of selection we might assume they are similar
to what they were in their last stages of functionality, i.e., before
becoming non-functional. Under this assumption, our results
would suggest that having co-localized AID overlapping and
Polη hotspots in the CDRs is a contributor to evolutionary
survival for an IGHV gene.

Polη (WA/TW) hotspots, a simple feature we suggested might
contribute to higher mutability (24).
While the nucleotide differences in the 56 functional human
IGHV genes, as well as the additional 32 non-functional genes,
are obvious, the forces that have driven those differences are
still unclear, and we do not understand how exactly they relate
to each other and have co-evolved in terms of mutability. This
is of particular importance because the special characteristics
of the germline sequences that have evolved and been retained
allow us to make antibodies to every possible foreign substance
and infectious agent (36). To begin to address this question, we
generated profiles describing the frequencies of AID overlapping
hotspots (WGCW) for all functional human IGHV genes, and
identified regions of high frequency not only in the CDRs,
as would be expected, but also in a sub-region of FW1
and another in FW3 that has been referred to as “CDR4”
(Figure 1B) (29). Beyond the characteristics of the CDRs and
the FWs, there are clear sequence differences and patterns
between the families and within each family that can be seen
visually (Figures S1, S2). However, it has not been possible to
determine which of these differences are most important in
driving the evolution of the germline V region sequences to
produce the antibody diversity that we require while retaining
the structural integrity of the antibody structure. We therefore
applied Principal Components Analysis (PCA), a form of
dimensionality reduction that works to maximally capture the
variance of the original data, to the WGCW profiles for all
functional IGHV genes. We first found that, when comparing
the distribution of AID overlapping hotspots, most variation
in the hotspot distribution—as reflected in the loadings for
the first two principal components (Figure 2B)—was primarily
dependent on sites in FW3 (together with some sites in FW1)
and in CDR1. The tight cluster of overlapping hotspots at the
5′ end of FW1 is particularly interesting because it is so highly

DISCUSSION
Since the discovery of AID (34), many details of the mechanisms
associated with somatic hypermutation of antibody V regions
have been elucidated, in particular, the roles of ncBER and
ncMMR repair mechanisms that act downstream of the
original AID-mediated mutation (3, 6, 7, 35). Biochemical
characterization of AID and of Polη, a key polymerase involved
in ncMMR, led to a better understanding of their preferences for
the hotspots (WRC and WA respectively) (3). Further analyses
of unselected in vivo data from the human IGHV3-23 gene
confirmed that overlapping hotspots, defined by the hotspot
WGCW, were particularly highly mutated in human IGHV
genes (25). Analysis of the same IGHV3-23 dataset by ourselves
showed that mutations in two particular WGCW hotspots were
associated with mutations throughout the V gene, and that these
highly mutated WGCW sites tended to be close to clusters of
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majority of human IGHV genes. Analysis of the co-localization
profiles revealed a pattern whereby CDR1 and CDR2 were the
primary contributors to variation, as one might expect given the
increased potential of the CDRs for interaction with antigen. In
comparison, FW3 was less impactful and FW1 did not seem to
play a role at all, which contrasted with the previous observations
on the WGCW-only profiles. The relative importance of “CDR4”
sub-region of FW3 in the WGCW-only profiles may be related
to a previously proposed mutation model (37, 38) where cooccurring pairs of mutations demarcate sub-regions that are
subsequently repaired by ncMMR. Under this model, WA
hotspots between highly targeted AID hotspots (e.g., in CDR2)
would presumably be targeted by Polη, while the original AID
mutations at the boundaries (e.g., in FW1 or “CDR4”) might
be repaired. Further mutations at AID hotspots may be possible
within the exposed ssDNA patch due to the greater efficiency
of UNG activity on ssDNA (39). The mutation pair model may
also explain the results we observed when analyzing WGCW
sites alone (Figure 2B), which shows CDR2 as less variable than
“CDR4” and CDR1, since paired mutations in “CDR4” and CDR1
might lead to CDR2 mutations when the ssDNA patch includes
CDR2. Interestingly, the three IGHV3 family genes, IGHV321, IGHV3-48, and IGHV3-30 highlighted above as having no
overlapping hotspots in CDR2 (gray arrows on the left side
of the plot of Figure 4A) do, however, have a high abundance
of WA/TW sites in CDR1 (Figure S6A). At the same time,
mutations in “CDR4” may be selected for directly, as appears
to be the case for anti-influenza broadly-neutralizing antibodies,
where FW3 residues form a loop that interacts directly with
antigen (40, 41).
When we further incorporated non-functional genes (i.e.,
open reading frame genes and pseudogenes) into the analysis,
the overall co-localized WGCW/WA signal was markedly
reduced in both CDRs, while the variation in FW3 remained
roughly the same in comparison to the functional genes. A
characteristic observed in many of the non-functional genes
is an absence of AID overlapping hotspots in their CDRs
(Figure S7), which may explain their loss in functionality, and
perhaps can give us further insight into predicting future
pseudogenes from the pool of presently functional IGHV genes
(for example, IGHV1-8, which lacks WGCW sites in either CDR1
or CDR2).
In summary, a simple measure describing the co-localization
of WGCW and WA/TW hotspots appears to capture key aspects
of variation of mutability in human IGHV genes, and suggests
that this co-localization in highly mutating sub-regions such as
the CDRs has contributed to shaping the evolution of the human
IGHV genes.

conserved within each of the families except IGHV2 where it is
not present (Figures S1, S2). This sub-region is at the very Nterminal end of the V region and, based on the crystal structure
of IGHV3-23∗ 01, is unlikely to come in direct contact with
antigen (24). This sub-region is also rich in AGCTs and, again
in IGHV3-23∗ 01, these are mutated in many V genes but at a
much lower frequency than the AGCTs in other parts of the
gene (24). Furthermore, in IGHV3-23∗ 01 sequences that have
not undergone mutations at those sites, there is an overall lower
frequency of somatic mutation throughout the gene compared to
IGHV genes in which they have been mutated, suggesting that
they do have some association with the AID mutational process
(24). We also do not understand the role of the overlapping
TGCA AID hotspots that are in FW1 just 5′ to CDR1 in all of the
IGHV1, 2, and almost all IGHV3 family members, but missing
from some IGHV5 and IGHV4 family members (Figures S1, S2).
This site is not highly mutated in any of those families, but the
fact that it is so highly retained and always a TGCA motif suggests
it does have some role.
The number of functional IGHV genes varies greatly between
the seven different IGHV families with IGHV6 and IGHV7
having only one productive germline gene each, and the IGHV3
family containing the most, with 25 functional members. The
reasons for these differences are unclear. In our analysis of
WGCW hotspots, variation in CDR2 appeared to be relatively
low although, interestingly, the loadings along the first principal
component (PC1) for FW3 (together with some sites in FW1)
and CDR2 are located in opposing directions, indicating that
their patterns of WGCW hotspots were negatively correlated.
The major differences between IGHV families along PC1, in
terms of overlapping hotspots, were found primarily in the
FW3 (“CDR4”) and FW1 sites, whereas the loadings along
PC2 largely corresponded to CDR1 sites. Since, by definition,
PC1 and PC2 are independent, the pattern of WGCW sites
in CDR1 was uncorrelated with that of CDR2, as well as
FW1/FW3 (Figures S5C,D). It was also evident that CDR1
mainly contributed to the hotspot variation seen between
IGHV genes that are members of the same family (intra-family
differences). We can further speculate that the pattern of WGCW
sites in the FW1/FW3 sub-region that is largely conserved within
each family, may facilitate different levels of hotspot evolution
within the family. Different families indeed appear to have
different levels of variation. For example, if we consider the three
largest IGHV families (see Figure S8A, showing variation for
the IGHV1, 3 and 4 families), the IGHV1 and IGHV3 families
tend toward greater variation in the CDRs than does IGHV4
(Figure S8B, shows corresponding variation averages for each
FW and CDR sub-regions).
We next considered the potential for interactions between
AID overlapping (WGCW) and Polη (WA/TW) hotspots. We
defined a basic measure for co-localization of AID and Polη
hotspots, and then used it to define profiles for the 56 functional
human IGHV genes. Using high-throughput mutation data, we
verified that sites contained within co-localized WGCW/WA
sub-regions were indeed more significantly mutated in the

Frontiers in Immunology | www.frontiersin.org

DATA AVAILABILITY STATEMENT
The datasets generated for this study can be found in
the NCBI SRA BioProject IDs 381394, 591804 (https://
www.ncbi.nlm.nih.gov/bioproject/381394; http://www.ncbi.nlm.
nih.gov/bioproject/591804).

12

April 2020 | Volume 11 | Article 788

Tang et al.

Evolutionary Variation of Antibody Genes

AUTHOR CONTRIBUTIONS

grant agreement REPTOL No 794075. The funders had no
role in study design, data collection, and interpretation or
the decision to submit the work for publication. NC was
funded by philanthropic contributions from the Karches
Family, The Nash Family Foundation, The Marks Foundation,
and the Jean Walton Fund for Leukemia, Lymphoma, and
Myeloma Research.

CT and TM designed the research and methods. NC and DB
provided the data. DB pre-processed the data. CT and TM
performed the data analysis. CT, MS, and TM prepared the
manuscript. All co-authors read and approved manuscript.

FUNDING

SUPPLEMENTARY MATERIAL

This work was supported by grants NIH R01GM111741 to
TM and NIH R01AI132507 to TM and MS. DB has received
funding from the European Union’s Horizon 2020 research
and innovation program under the Marie Skłodowska-Curie

The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fimmu.
2020.00788/full#supplementary-material

REFERENCES

17. Hershberg U, Shlomchik MJ. Differences in potential for amino acid
change after mutation reveals distinct strategies for kappa and lambda
light-chain variation. Proc Natl Acad Sci USA. (2006) 103:15963–8.
doi: 10.1073/pnas.0607581103
18. Saini J, Hershberg U. B cell variable genes have evolved their codon
usage to focus the targeted patterns of somatic mutation on the
complementarity determining regions. Mol Immunol. (2015) 65:157–67.
doi: 10.1016/j.molimm.2015.01.001
19. Sheng Z, Schramm CA, Kong R, Program NCS, Mullikin JC, Mascola JR, et al.
Gene-specific substitution profiles describe the types and frequencies of amino
acid changes during antibody somatic hypermutation. Front Immunol. (2017)
8:537. doi: 10.3389/fimmu.2017.00537
20. Rogozin IB, Kolchanov NA. Somatic hypermutagenesis in immunoglobulin
genes. II Influence of neighbouring base sequences on mutagenesis. Biochim
Biophys Acta. (1992) 1171:11–8. doi: 10.1016/0167-4781(92)90134-L
21. Pham P, Bransteitter R, Petruska J, Goodman MF. Processive AIDcatalysed cytosine deamination on single-stranded DNA simulates somatic
hypermutation. Nature. (2003) 424:103–7. doi: 10.1038/nature01760
22. Rogozin IB, Diaz M. Cutting edge: DGYW/WRCH is a better predictor
of mutability at G:C bases in Ig hypermutation than the widely accepted
RGYW/WRCY motif and probably reflects a two-step activation-induced
cytidine deaminase-triggered process. J Immunol. (2004) 172:3382–4.
doi: 10.4049/jimmunol.172.6.3382
23. Yu K, Huang FT, Lieber MR. DNA substrate length and surrounding sequence
affect the activation-induced deaminase activity at cytidine. J Biol Chem.
(2004) 279:6496–500. doi: 10.1074/jbc.M311616200
24. Wei L, Chahwan R, Wang S, Wang X, Pham PT, Goodman MF, et al.
Overlapping hotspots in CDRs are critical sites for V region diversification.
Proc Natl Acad Sci USA. (2015) 112:E728–37. doi: 10.1073/pnas.1500788112
25. Ohm-Laursen L, Barington T. Analysis of 6912 unselected somatic
hypermutations in human VDJ rearrangements reveals lack of strand
specificity and correlation between phase II substitution rates and distance to
the nearest 3′ activation-induced cytidine deaminase target. J Immunol. (2007)
178:4322–34. doi: 10.4049/jimmunol.178.7.4322
26. Yeap LS, Hwang JK, Du Z, Meyers RM, Meng FL, Jakubauskaite A, et al.
Sequence-intrinsic mechanisms that target AID mutational outcomes on
antibody genes. Cell. (2015) 163:1124–37. doi: 10.1016/j.cell.2015.10.042
27. Hwang JK, Wang C, Du Z, Meyers RM, Kepler TB, Neuberg D, et al. Sequence
intrinsic somatic mutation mechanisms contribute to affinity maturation of
VRC01-class HIV-1 broadly neutralizing antibodies. Proc Natl Acad Sci USA.
(2017) 114:8614–9. doi: 10.1073/pnas.1709203114
28. Matsuda T, Bebenek K, Masutani C, Rogozin IB, Hanaoka F, Kunkel TA. Error
rate and specificity of human and murine DNA polymerase eta. J Mol Biol.
(2001) 312:335–46. doi: 10.1006/jmbi.2001.4937
29. Kehoe JM, Capra JD. Localization of two additional hypervariable regions in
immunoglobulin heavy chains. Proc Natl Acad Sci USA. (1971) 68:2019–21.
doi: 10.1073/pnas.68.9.2019
30. Vergani S, Korsunsky I, Mazzarello AN, Ferrer G, Chiorazzi N, Bagnara
D. Novel method for high-throughput full-length IGHV-D-J sequencing of

1. Rajewsky K. Clonal selection and learning in the antibody system. Nature.
(1996) 381:751–8. doi: 10.1038/381751a0
2. Methot SP, Di Noia JM. Molecular mechanisms of somatic hypermutation
and class switch recombination. Adv Immunol. (2017) 133:37–87.
doi: 10.1016/bs.ai.2016.11.002
3. Pilzecker B, Jacobs H. Mutating for good: DNA damage responses
during somatic hypermutation. Front Immunol. (2019) 10:438.
doi: 10.3389/fimmu.2019.00438
4. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class
switch recombination and hypermutation require activation-induced cytidine
deaminase (AID), a potential RNA editing enzyme. Cell. (2000) 102:553–63.
doi: 10.1016/S0092-8674(00)00078-7
5. Bransteitter R, Pham P, Scharff MD, Goodman MF. Activation-induced
cytidine deaminase deaminates deoxycytidine on single-stranded DNA but
requires the action of RNase. Proc Natl Acad Sci USA. (2003) 100:4102–7.
doi: 10.1073/pnas.0730835100
6. Di Noia JM, Neuberger MS. Molecular mechanisms of antibody
somatic hypermutation. Annu Rev Biochem. (2007) 76:1–22.
doi: 10.1146/annurev.biochem.76.061705.090740
7. Rada C, Di Noia JM, Neuberger MS. Mismatch recognition and uracil
excision provide complementary paths to both Ig switching and the
A/T-focused phase of somatic mutation. Mol Cell. (2004) 16:163–71.
doi: 10.1016/j.molcel.2004.10.011
8. Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA.
Contribution of DNA polymerase eta to immunoglobulin gene hypermutation
in the mouse. J Exp Med. (2005) 201:1191–6. doi: 10.1084/jem.20050292
9. Mayorov VI, Rogozin IB, Adkison LR, Gearhart PJ. DNA polymerase eta
contributes to strand bias of mutations of A versus T in immunoglobulin
genes. J Immunol. (2005) 174:7781–6. doi: 10.4049/jimmunol.174.12.7781
10. Shapiro GS, Aviszus K, Ikle D, Wysocki LJ. Predicting regional mutability in
antibody V genes based solely on di- and trinucleotide sequence composition.
J Immunol. (1999) 163:259–68.
11. Shapiro GS, Aviszus K, Murphy J, Wysocki LJ. Evolution of Ig DNA sequence
to target specific base positions within codons for somatic hypermutation. J
Immunol. (2002) 168:2302–6. doi: 10.4049/jimmunol.168.5.2302
12. Cohen RM, Kleinstein SH, Louzoun Y. Somatic hypermutation targeting is
influenced by location within the immunoglobulin V region. Mol Immunol.
(2011) 48:1477–83. doi: 10.1016/j.molimm.2011.04.002
13. Gojobori T, Nei M. Concerted evolution of the immunoglobulin VH gene
family. Mol Biol Evol. (1984) 1:195–212.
14. Tanaka T, Nei M. Positive darwinian selection observed at the variable-region
genes of immunoglobulins. Mol Biol Evol. (1989) 6:447–59.
15. Chang B, Casali P. The CDR1 sequences of a major proportion of human
germline Ig VH genes are inherently susceptible to amino acid replacement.
Immunol Today. (1994) 15:367–73. doi: 10.1016/0167-5699(94)90175-9
16. Wagner SD, Milstein C, Neuberger MS. Codon bias targets mutation. Nature.
(1995) 376:732. doi: 10.1038/376732a0

Frontiers in Immunology | www.frontiersin.org

13

April 2020 | Volume 11 | Article 788

Tang et al.

31.

32.

33.
34.

35.

36.

37.

Evolutionary Variation of Antibody Genes

38. Zivojnovic M, Delbos F, Girelli Zubani G, Jule A, Alcais A, Weill JC, et al.
Somatic hypermutation at A/T-rich oligonucleotide substrates shows different
strand polarities in Ung-deficient or -proficient backgrounds. Mol Cell Biol.
(2014) 34:2176–87. doi: 10.1128/MCB.01452-13
39. Frieder D, Larijani M, Collins C, Shulman M, Martin A. The concerted
action of Msh2 and UNG stimulates somatic hypermutation at A.
T base pairs Mol Cell Biol. (2009) 29:5148–57. doi: 10.1128/MCB.
00647-09
40. Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M,
et al. Antibody recognition of a highly conserved influenza virus epitope.
Science. (2009) 324:246–51. doi: 10.1126/science.1171491
41. Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, et al. Structural
and functional bases for broad-spectrum neutralization of avian and
human influenza A viruses. Nat Struct Mol Biol. (2009) 16:265–73.
doi: 10.1038/nsmb.1566

the immune repertoire from bulk B-cells with single-cell resolution. Front
Immunol. (2017) 8:1157. doi: 10.3389/fimmu.2017.01157
Ohm-Laursen L, Nielsen M, Larsen SR, Barington T. No evidence for the use
of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement
in the peripheral repertoire was found on application of an improved
algorithm, JointML, to 6329 human immunoglobulin H rearrangements.
Immunology. (2006) 119:265–77. doi: 10.1111/j.1365-2567.2006.02431.x
Gadala-Maria D, Yaari G, Uduman M, Kleinstein SH. Automated analysis of
high-throughput B-cell sequencing data reveals a high frequency of novel
immunoglobulin V gene segment alleles. Proc Natl Acad Sci USA. (2015)
112:E862–70. doi: 10.1073/pnas.1417683112
Lefranc MP. IMGT, the international immunogenetics database. Nucleic Acids
Res. (2001) 29:207–9. doi: 10.1093/nar/29.1.207
Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, Davidson
NO, et al. Specific expression of activation-induced cytidine deaminase (AID),
a novel member of the RNA-editing deaminase family in germinal center B
cells. J Biol Chem. (1999) 274:18470–6. doi: 10.1074/jbc.274.26.18470
Peled JU, Kuang FL, Iglesias-Ussel MD, Roa S, Kalis SL, Goodman MF, et al.
The biochemistry of somatic hypermutation. Annu Rev Immunol. (2008)
26:481–511. doi: 10.1146/annurev.immunol.26.021607.090236
Collins AM, Jackson KJL. On being the right size: antibody repertoire
formation in the mouse and human. Immunogenetics. (2017).
doi: 10.1007/s00251-017-1049-8
Schanz S, Castor D, Fischer F, Jiricny J. Interference of mismatch and base
excision repair during the processing of adjacent U/G mispairs may play a key
role in somatic hypermutation. Proc Natl Acad Sci USA. (2009) 106:5593–8.
doi: 10.1073/pnas.0901726106

Frontiers in Immunology | www.frontiersin.org

Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Tang, Bagnara, Chiorazzi, Scharff and MacCarthy. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.

14

April 2020 | Volume 11 | Article 788

